Reply to 'Evidence-based review, not change in usage patterns, should drive Medicare Benefit Schedule (MBS) disinvestment decisions'.

Subjects

Subjects :

OSTEOARTHRITIS treatment
KNEE diseases
INJECTIONS
HEALTH insurance reimbursement
PLATELET-rich plasma
THERAPEUTICS

Details

Language :

English

ISSN :

01565788

Volume :

41

Issue :

6

Database :

Complementary Index

Journal :

Australian Health Review

Publication Type :

Academic Journal

Accession number :

126511538

Full Text :

https://doi.org/10.1071/AH16239